Aquestive Therapeutics (AQST) Gross Margin (2017 - 2026)
Aquestive Therapeutics (AQST) recorded Gross Margin of 52.28% in Q3 2026, down 12.53 percentage points from 64.82% a year earlier and down 18.65 percentage points from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Gross Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Aquestive Therapeutics' Gross Margin came in at 65.34% as of Sep 30, 2026, up 5.06 percentage points year-over-year; for FY2025, it was 58.35%, down 10.61 percentage points from FY2024.
- Annual Gross Margin has a five-year change of -13.38 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 68.95% in FY2024 (+10.13 pp), 58.82% in FY2023 (-0.52 pp), 59.34% in FY2022 (-11.17 pp) and 70.51% in FY2021 (-1.21 pp).
- The Q3 2026 figure is the lowest quarterly Gross Margin since Q2 2023.
- On a year-over-year basis, Gross Margin rose in two of the last eight quarters, with an average year-over-year change of -2.31 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 27.46 percentage points in Q2 2024, against a drop of 23.08 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 70.93% (Q2 2026), 75.99% (Q1 2026) and 55.16% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 75.71% |
| 10 | Aquestive Therapeutics | 445.70 Mn | 24.96 Mn | 3.95 Mn | 52.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 52.28% |
| Jun 30, 2026 | 70.93% |
| Mar 31, 2026 | 75.99% |
| Dec 31, 2025 | 55.16% |
| Sep 30, 2025 | 64.82% |
| Jun 30, 2025 | 54.40% |
| Mar 31, 2025 | 58.12% |
| Dec 31, 2024 | 61.91% |
| Sep 30, 2024 | 67.24% |
| Jun 30, 2024 | 77.48% |
| Mar 31, 2024 | 63.59% |
| Dec 31, 2023 | 64.57% |
| Sep 30, 2023 | 63.10% |
| Jun 30, 2023 | 50.03% |
| Mar 31, 2023 | 57.45% |
| Dec 31, 2022 | 50.34% |
| Sep 30, 2022 | 59.65% |
| Jun 30, 2022 | 60.48% |
| Mar 31, 2022 | 65.66% |
| Dec 31, 2021 | 69.62% |
API Access
Aquestive Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();